Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma.
Preetesh JainShuangtao ZhaoJee Hun LeeHolly A HillChi Young OkRashmi Kanagal-ShamanaFredrick B HagemeisterNathan FowlerLuis FayadYixin YaoYang LiuOmar B MoghrabiLucy NavsariaLei FengGraciela M Nogueras GonzalezGuofan XuSelvi ThirumurthiDavid A SantosCezar IliescuGuillin TangL Jeffrey MedeirosFrancisco VegaMichelle AvellanedaMaria BadilloChristopher R FlowersLinghua WangMichael L WangPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
IR combination is effective in older patients with MCL. Baseline evaluation for cardiovascular risks is highly recommended. Randomized trial is needed for definitive conclusions.